These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5756138)

  • 41. The prognostic implications of anaemia in the outcome of patients with early stages of uterine cervix carcinoma.
    Martin-Loeches M; Ortí RM; Asins E; Llixiona J
    Arch Gynecol Obstet; 2003 Jan; 267(3):121-5. PubMed ID: 12552320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of recurrent cervical cancer].
    Takamizawa H; Kasai T; Arai T
    Gan No Rinsho; 1983 Aug; 29(10):1079-84. PubMed ID: 6632194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pretherapeutic evaluation of cancers of the uterine cervix in young women: are there any specific prognostic factors?].
    Lartigau E; Gerbaulet A; Haie-Meder C; Marsiglia H; Michel G; Prade M; Lhommé C
    Bull Cancer Radiother; 1994; 81(4):413-7. PubMed ID: 7702928
    [No Abstract]   [Full Text] [Related]  

  • 44. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recurrence and metastases of cervical and uterine cancer treated with a combination of radium and surgery].
    Dargent M; Dargent D
    Minerva Ginecol; 1968 Feb; 20(3):186-97. PubMed ID: 5741552
    [No Abstract]   [Full Text] [Related]  

  • 46. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
    Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
    Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical evaluation of serum CEA levels in uterine cervix cancer].
    Kikuchi Y; Hirose J; Uekita Y; Hayasaka K; Asano A; Nishino S; Mitsuhashi H; Amo K; Washizuka N; Mure I; Yamashita Y
    Gan No Rinsho; 1983 Apr; 29(4):A-21, 330-5. PubMed ID: 6854968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of early and locally advanced cervical cancer.
    Barbera L; Thomas G
    Semin Oncol; 2009 Apr; 36(2):155-69. PubMed ID: 19332250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Primary malignant melanoma of the uterine cervix--case report and review of the literature].
    Räber G; Mempel V; Jackisch C; Patt V; Schneider HP
    Zentralbl Gynakol; 1993; 115(11):503-7. PubMed ID: 8296497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
    Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
    Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB.
    Kainz C; Gitsch G; Tempfer C; Heinzl H; Koelbl H; Breitecker G; Reinthaller A
    Anticancer Res; 1994; 14(5B):2245-8. PubMed ID: 7840530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Surgical treatment of cervix cancer. A 6-year material from a regional hospital].
    Hagen B; Skjeldestad FE; Tingulstad S; Onsrud M; Halvorsen T
    Tidsskr Nor Laegeforen; 1994 Sep; 114(22):2603-5. PubMed ID: 7985176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors in postoperative management of cervical cancer; a statistical study.
    Maeda T; Okamura S; Ueki M; Sugimoto O
    Bull Osaka Med Sch; 1986 Jul; 32(1):9-21. PubMed ID: 3115343
    [No Abstract]   [Full Text] [Related]  

  • 55. [Severity factors in uterine cancer].
    Găleşanu MR; Bild E; Ciornea D; Rusu E; Dăneţ D
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):643-6. PubMed ID: 3835659
    [No Abstract]   [Full Text] [Related]  

  • 56. [Invasive cervical cancer in young women (author's transl)].
    Kucera H; Kubista E; Kupka S
    Geburtshilfe Frauenheilkd; 1974 Dec; 34(12):1029-33. PubMed ID: 4457386
    [No Abstract]   [Full Text] [Related]  

  • 57. [Remote results of radical treatment of cervical cancer].
    Kosareva AN; Mirotvortseva KS
    Vopr Onkol; 1971; 17(1):72-7. PubMed ID: 5574583
    [No Abstract]   [Full Text] [Related]  

  • 58. [Parametrial evaluation by puncture biopsy in recurrent uterine cervix cancer].
    Cabezón C; Oddó D; Castillo R; Aliste G
    Rev Chil Obstet Ginecol; 1988; 53(1):9-14. PubMed ID: 3275080
    [No Abstract]   [Full Text] [Related]  

  • 59. [Early detection of recurrence of malignant gynecologic tumors].
    Hashimoto K
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Jul; 23(7):618-9. PubMed ID: 5107171
    [No Abstract]   [Full Text] [Related]  

  • 60. [Autopsy findings and clinical course of patients with cancer of the uterine cervix].
    Nakanishi T; Kasamatsu T; Sonoda T; Matsumoto Y; Yamaoda K
    Gan No Rinsho; 1969 Aug; 15(8):723-8. PubMed ID: 5388917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.